Parameter
| Biomarker | miR-210 | Full name | MicroRNA-210 | Molecular Type | Nucleic acid (RNA) |
|---|---|---|---|---|---|
| Molecular Formula | Molecular Weight | 6.6 kDa | Core Functional Dimensions | Prognosis and therapeutic targets | |
| Disease | Angiosarcoma | Disease Subtypes | / | ||
| Organ | Tumor cells, immune cells | Test Sample / Technology Platform | Tissue/serum (qRT-PCR, NGS) | ||
| Pathobiological Mechanisms | Tumor suppressor miRNA, down-regulation promotes the proliferation of angiosarcoma cells | ||||
| Clinical Availability Status | Study validation: Subtype-specific expression | ||||
| Notes and Dynamics | Targeting E2F3 and ephrin A3, downregulation is associated with poor prognosis | ||||